Key result
Use of the GAP discharge tool was independently protective against death at 1 year in women with acute myocardial infarction (adjusted OR 0.46; 95% CI 0.27-0.79).
Why the study?
Does the GAP program improve the use of evidence-based therapies and reduce mortality in men and women with acute myocardial infarction?
Population
Male and female patients with acute myocardial infarction (AMI) in Michigan
Comparison
American College of Cardiology's AMI Guidelines… vs Pre-GAP standard of care
Design
Cohort
Follow-up
1 year
Authors
Loading...
May support GAP tool use in women with AMI; leaves open causal confirmation in randomized trials.
Observational
Does the GAP program improve the use of evidence-based therapies and reduce mortality in men and women with acute myocardial infarction?
Odds Ratio: 0.46 (95% CI 0.27–0.79)
Implementation of the GAP program increased the use of evidence-based therapies and its discharge tool was associated with reduced 1-year mortality, particularly in women, highlighting the need to address its underutilization in female patients.
Sandeep M. Jani (2006) conducted an observational in Acute myocardial infarction. GAP program discharge tool vs. Non-use of discharge tool / pre-GAP sample was evaluated on Death at 1 year in women (adjusted OR 0.46, 95% CI 0.27-0.79). Use of the GAP discharge tool was independently protective against death at 1 year in women with acute myocardial infarction (adjusted OR 0.46; 95% CI 0.27-0.79).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: